1. Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy. (9th October 2019) Authors: van De Ven, Nikolien S; Pozniak, Anton L; Levi, Jacob A; Clayden, Polly; Garratt, Anna; Redd, Christopher; Mofenson, Lynne M; Hill, Andrew Journal: Clinical infectious diseases Issue: Volume 70:Number 12(2020) Page Start: 2599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Choice of antiretroviral drugs for continued treatment scale‐up in a public health approach: what more do we need to know?. Issue 1 (2nd February 2016) Authors: Vitoria, Marco; Hill, Andrew M; Ford, Nathan P; Doherty, Meg; Khoo, Saye H; Pozniak, Anton L Journal: Journal of the International AIDS Society Issue: Volume 19:Issue 1(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COVID-19 death in people with HIV: interpret cautiously. Issue 1 (January 2021) Authors: Waters, Laura J; Pozniak, Anton L Journal: Lancet Issue: Volume 8:Issue 1(2021) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment. Issue 8 (August 2017) Authors: Salam, Alex P; Pozniak, Anton L Journal: Lancet infectious diseases Issue: Volume 17:Issue 8(2017:Aug.) Page Start: 882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dolutegravir–rilpivirine for virological suppression. Issue 9 (September 2019) Authors: Pozniak, Anton L; Arribas, Jose R Journal: Lancet Issue: Volume 6:Issue 9(2019) Page Start: e560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First-line integrase inhibitors for HIV—prices versus benefits. Issue 11 (November 2016) Authors: Pozniak, Anton L; Hill, Andrew M Journal: Lancet Issue: Volume 3:Issue 11(2016) Page Start: e500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?. Issue 7 (18th July 2019) Authors: Rockwood, Neesha; Cerrone, Maddalena; Barber, Melissa; Hill, Andrew M; Pozniak, Anton L Journal: Journal of the International AIDS Society Issue: Volume 22:Issue 7(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practice. Issue 2 (14th October 2016) Authors: White, Helena A; Miller, Robert F; Pozniak, Anton L; Lipman, Marc C I; Stephenson, Iain; Wiselka, Martin J; Pareek, Manish Journal: Thorax Issue: Volume 72:Issue 2(2017) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects. Issue 7 (12th July 2019) Authors: Mofenson, Lynne M; Pozniak, Anton L; Wambui, Jacque; Raizes, Elliot; Ciaranello, Andrea; Clayden, Polly; Ehrenkranz, Peter; Fakoya, Ade; Hill, Andrew; Khoo, Saye; Mahaka, Imelda; Modi, Surbhi; Moore, Cynthia; Phillips, Andrew; Siberry, George; Sikwese, Kenly; Thorne, Claire; Watts, Heather D; Doh... Journal: Journal of the International AIDS Society Issue: Volume 22:Issue 7(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗